Skip to main content

Advertisement

Log in

Orbital Inflammatory Pseudotumors: Etiology, Differential Diagnosis, and Management

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Orbital inflammation is typically an idiopathic process that occasionally may be identified with a specific local or systemic disease as the causative agent. Orbital inflammatory pseudotumor (also known as idiopathic orbital inflammation syndrome, orbital pseudotumor, nonspecific orbital inflammation, and orbital inflammatory syndrome) is defined as an idiopathic tumor-like inflammation consisting of a pleomorphic cellular response and a fibrovascular tissue reaction. Various rheumatologic disorders are associated with orbital inflammation and must be ruled out in cases of orbital inflammatory pseudotumor, including Wegener’s granulomatosis, giant cell arteritis, systemic lupus erythematosus, dermatomyositis, and rheumatoid arthritis. The mainstay of therapy is corticosteroid therapy, although there is an increasing trend toward use of antimetabolites, alkylating agents, cytotoxic agents, and other immunosuppressive agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Jacobs D, Galetta S: Diagnosis and management of orbital pseudotumor. Ophthalmology 2002, 13:347–351.

    Google Scholar 

  2. Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L: What is orbital pseudotumor? Surv Ophthalmol 1996, 41:66–78.

    Article  CAS  PubMed  Google Scholar 

  3. Yuen SJA, Rubin PAD: Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin North Am 2002, 15:121–126.

    Article  PubMed  Google Scholar 

  4. Alshaikh M, Kakakios AM, Kemp AS: Orbital myositis following streptococcal pharyngitis. J Paediatr Child Health 2008, 44:233–234.

    Article  PubMed  Google Scholar 

  5. Mackie SL, Keat A: Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology 2004, 43:949–954.

    Article  CAS  PubMed  Google Scholar 

  6. Dale RC, Candler PM, Church AJ, et al.: Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 2006, 172:187–197.

    Article  CAS  PubMed  Google Scholar 

  7. Venuta A, Ferrari P, Beverelli A, et al.: Acute post-streptococcal polymyalgia: two new cases with a review of the literature. Eur J Pediatr 1995, 154:475–476.

    Article  CAS  PubMed  Google Scholar 

  8. Nieto JC, Kim N, Lucarelli MJ: Dacryoadenitis and orbital myositis associated with lyme disease. Arch Ophthalmol 2008, 126:1165–1166.

    Article  PubMed  Google Scholar 

  9. Kawasaki A, Borruat FX: An unusual presentation of herpes zoster ophthalmicus: orbital myositis preceding vesicular eruption. Am J Ophthalmol 2003, 136:574–575.

    Article  PubMed  Google Scholar 

  10. Badilla J, Dolman P: Orbital myositis involving the oblique muscles associated with herpes zoster ophthalmicus. Ophthal Plast Reconstr Surg 2007, 23:411–413.

    Article  PubMed  Google Scholar 

  11. Volpe NJ, Shore JW: Orbital myositis associated with herpes zoster. Arch Ophthalmol 1991, 109:471–472.

    CAS  PubMed  Google Scholar 

  12. Sobrin L, Kim E, Christen W, et al.: Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol 2007, 125:895–900.

    Article  CAS  PubMed  Google Scholar 

  13. Garrity JA, Coleman AW, Matteson EL, et al.: Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol 2004, 138:925–930.

    Article  CAS  PubMed  Google Scholar 

  14. Atabay C, Tyutyunikov A, Scalise D, et al.: Serum antibodies reactive with eye muscle membrane antigens are detected in patients with nonspecific orbital inflammation. Ophthalmology 1995, 102:145–153.

    CAS  PubMed  Google Scholar 

  15. Yuen SJA, Rubin PAD: Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003, 121:491–499.

    Article  PubMed  Google Scholar 

  16. Lanciano R, Fowble B, Sergott RC, et al.: The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys 1990, 18:407–411.

    CAS  PubMed  Google Scholar 

  17. Sergott R, Glaser J, Charyulu K: Radiotherapy for idiopathic inflammatory orbital pseudotumor: indications and results. Arch Ophthalmol 1981, 99:8536.

    Google Scholar 

  18. Orcutt J, Garner A, Henk J, Wright J: Treatment of idiopathic inflammatory orbital pseudotumors by radiotherapy. Br J Ophthalmol 1983, 67:570–574.

    Article  CAS  PubMed  Google Scholar 

  19. Smitt MC, Donaldson SS: Radiation therapy for benign disease of the orbit. Semin Radiat Oncol 1999, 9:179–189.

    Article  CAS  PubMed  Google Scholar 

  20. Zacharopoulos IP, Papadaki T, Manor RS, Briscoe D: Treatment of idiopathic orbital inflammatory disease with cyclosporine-A: a case presentation. Semin Ophthalmol 2009, 24:260–261.

    Article  PubMed  Google Scholar 

  21. Bielory L, Frohman LP: Low-dose cyclosporine therapy of granulomatous optic neuropathy and orbitopathy. Ophthalmology 1991, 98:1732–1736.

    CAS  PubMed  Google Scholar 

  22. • Buell C, Koo J: Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol 2008, 7:741–748. This was a meta-analysis review of CsA use that examined its safety profile.

    PubMed  Google Scholar 

  23. Diaz-Llopis M, Menezo JL: Idiopathic inflammatory orbital pseudotumor and low-dose cyclosporine. Am J Ophthalmol 1989, 107:547–548.

    CAS  PubMed  Google Scholar 

  24. Falcini F, Simonini G, Resti M, Cimaz R: Recurrent orbital pain and diplopia in a 12 year old boy. Ann Rheum Dis 2002, 61:93–94.

    Article  CAS  PubMed  Google Scholar 

  25. Sanchez-Roman J, Varela-Aguilar JM, Bravo-Ferrer J, et al.: Idiopathic orbital myositis: treatment with cyclosporin. Ann Rheum Dis 1993, 52:84–85.

    Article  CAS  PubMed  Google Scholar 

  26. • Gumus K, Mirza GE, Cavanagh HD, Karakucuk S: Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature. Eye Contact Lens 2009, 35:275–278. This case report showed topical corticosteroid and CsA use to control orbital inflammation in a patient who did not achieve control and did not tolerate the side effects of oral corticosteroids and oral CsA.

    Article  PubMed  Google Scholar 

  27. Smith JR, Rosenbaum JT: A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 2001, 85:1220–1224.

    Article  CAS  PubMed  Google Scholar 

  28. Shah SS, Lowder CY, Schmitt MA, et al.: Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 1992, 99:1419–1423.

    CAS  PubMed  Google Scholar 

  29. Osborne S, Sims JL, Rosser PM: Short-term use of infliximab in a case of recalcitrant idiopathic orbital inflammatory disease. Clin Experiment Ophthalmol 2009, 37:897–900.

    Article  PubMed  Google Scholar 

  30. • Sahlin S, Lignell B, Williams M, et al.: Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol 2009, 87:906–908. This case report showed successful treatment with infliximab of a very difficult subset of OIP patients.

    Article  PubMed  Google Scholar 

  31. Miquel T, Abad S, Badelon I, et al.: Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents. Ophthal Plast Reconstr Surg 2008, 24:415–417.

    Article  PubMed  Google Scholar 

  32. Prendiville C, O’Doherty M, Moriarty P, Cassidy L: The use of infliximab in ocular inflammation. Br J Ophthalmol 2008, 92:823–825.

    Article  CAS  PubMed  Google Scholar 

  33. Wilson MW, Shergy WJ, Haik BG: Infliximab in the treatment of recalcitrant idiopathic orbital inflammation. Ophthal Plast Reconstr Surg 2004, 20:381–383.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Dr. Espinoza is partially supported by an unrestricted educational grant from Research to Prevent Blindness.

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriela M. Espinoza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Espinoza, G.M. Orbital Inflammatory Pseudotumors: Etiology, Differential Diagnosis, and Management. Curr Rheumatol Rep 12, 443–447 (2010). https://doi.org/10.1007/s11926-010-0128-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-010-0128-8

Keywords

Navigation